ACTRN12623001043628招募中Unknown
A pilot single-arm nurse and peer-led mobile hepatitis C testing and treatment clinic for people on community corrections orders, using rapid point-of-care testing technologies.
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 600
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Diagnosis
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •1. Aged at least 18 years;
- •2. Consenting to point-of-care fingerstick testing for hepatitis C;
- •3. Consent to provide full name, date of birth, contact details, Medicare number and general practitioner details (if available);
- •4. Not currently engaged in treatment for hepatitis C infection;
排除标准
- •1.. Unable or unwilling to undergo point-of-care hepatitis C RNA testing.
- •2. Unable or unwilling to provide informed consent
- •There are no other exclusion criteria for testing for hepatitis C infection, however there may be contraindication or caution to hepatitis C DAA treatment including:
- •a.receiving medications which are contraindicated to the co-administration of DAAs or at risk of significant drug-drug interaction;
- •b.pregnant or breastfeeding at the time of commenced of DAA therapy;
- •c.Individuals with decompensated chronic liver disease
- •These individuals will be referred to St Vincent’s Hospital for specialist consultation review.
研究者
相似试验
招募中
不适用
A study of providing adult smokers, who smoke at least one cigarette per day, the opportunity to sample a range of nicotine replacement therapies (NRTs) in everyday non-medical community locations, to determine if this is acceptable to smokers, and whether it increases their motivation to quit smoking, encourages them to use NRTs, and helps them to quit smoking and remain abstinent for three months.ACTRN12614000054617Ministry of Health1,000
尚未招募
Unknown
Early detection of oral cancer by ERLY SIGN Kit by using saliva sample.CTRI/2024/07/069769CURO Biosciences Private Limited
尚未招募
3 期
Evaluation of insertion of an Intrauterine contraceptive device using cross glide technologyCTRI/2024/01/060997Department of Obstetrics and Gynaecology, PGIMER, Chandigarh
进行中（未招募）
1 期
A single-center study to assess the effect of lamivudine (3TC) on cognitive impairment (alterations in thinking, learning, memory...) by the analysis of the plasma of patients with Mild Cognitive Impairment (MCI)Mild Cognitive impairment due to Alzheimer DiseaseMedDRA version: 27.0Level: LLTClassification code: 10090501Term: Mild cognitive impairment Class: 100000004852MedDRA version: 21.1Level: LLTClassification code: 10009846Term: Cognitive impairment Class: 10029205MedDRA version: 20.0Level: LLTClassification code: 10001896Term: Alzheimer's disease Class: 10029205CTIS2024-514330-20-00Fundacion Fls De Lucha Contra El Sida Las Enfermedades Infecciosas Y La Promocion De La Salud Y La Ciencia25
已完成
1 期
A prospective, single arm, single centre pilot trial to establish the safety and efficacy of the Oventus device to treat mild to moderate obstructive sleep apnoea and snoring.Mild to moderate obstructive sleep apnoeaSnoringRespiratory - Sleep apnoeaACTRN12615000028505Oventus Pty Ltd30